Keyword: Panacos Pharmaceuticals, Inc., Massachusetts

PANACOS PHARMACEUTICALS
Company Name PANACOS PHARMACEUTICALS, INC. 
Address  134 COOLIDGE RD. , WATERTOWN , MA , USA , 02472 
Type of Entity Foreign Corporation 
Years in Business 5  
 
 Top  
Stock Info (Source: MSN Money)
NamePanacos Pharmaceuticals Inc. 
Address134 Coolidge Avenue Watertown MA 02472 Phone: 617-9261551  
Phone617-9261551 
Fax617-9232276 
WebSitehttp://www.panacos.com/ 
Inductry TypeBiotechnology 
Employees32 
ExchangeNASDAQ 
Annual Sales426,000.0 
Income-37.7 Mil 
Quote6.42   More Quotes
DescriptionPanacos Pharmaceuticals, Inc. (Panacos), formerly known as V.I. Technologies, Inc., is a development-stage biotechnology company that seeks to develop next-generation, anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other major human viral diseases. The Company's lead product candidate, PA-457, is a once-daily oral HIV drug candidate in Phase II clinical testing. During the year ended December 31, 2005, Panacos completed a Phase IIa clinical trial of PA-457. The trial met its primary endpoint by demonstrating a reduction in the level of HIV in the blood, known as viral load, in patients treated with PA-457. In March 2005, V.I. Technologies, Inc. merged with Panacos Pharmaceuticals, Inc. (the former Panacos). Following the merger, the combined company was known as V.I. Technologies, Inc. until the name was changed to Panacos Pharmaceuticals, Inc. in August 2005. 
 Top  
Business Registration (Source: Massachusetts Secretary of State)
Legal Name of BusinessPANACOS PHARMACEUTICALS, INC. 
Entity TypeForeign Corporation 
Date Filed03/07/2001 
Identification Number:000744627 
Old Identification Number:000000000 
Current Fiscal Month / Day:12 / 31 
Previous Fiscal Month / Day:00 / 00 
Prinicpal Address134 COOLIDGE RD. , WATERTOWN , MA , USA , 02472 
Registered NameTHOMAS HIGGINS 
Registered Address134 COOLIDGE RD., , WATERTOWN , MA , USA , 02472 
The officers and all of the directors of the corporation:
Title Individual Name First, Middle, Last, Suffix Address (no PO Box) Address, City or Town, State, Zip Code Expiration of Term
PRESIDENT  JOHN BARR     134 COOLIDGE RD., WATERTOWN, MA 02472 USA     
TREASURER  THOMAS HIGGINS     134 COOLIDGE RD., WATERTOWN, MA 02472 USA     
 Click here to view business entity filings 
 Top  
The search was successfully completed, however no contact informations were found
Click here to view links to Contact Information for this company
 Top  
PANACOS PHARMACEUTICALS
The search was successfully completed, however no Trade Directory listings were found
 Top  
PANACOS PHARMACEUTICALS
Company Name   Panacos Pharmaceuticals
Address   134 Coolidge Avenue Watertown MA 02472 USA
Website   http://www.panacos.com
Phone   1 617 926 1551
Fax   1 617 923 2245
Ticker   NASDAQ National Market Ticker: PANC
Total Employee   32
Turn Over   (US$ '000): 1,000
Financial Year End   December
Relevance Score   100 %
 Top  
PANACOS PHARMACEUTICALS
Company Name   Panacos Pharmaceuticals, Inc.
Address   134 Coolidge Ave. Watertown, MA 02472
Website   http://www.panacos.com
Phone   617-926-1551
Fax   617-923-2245
Company Type   Public (NASDAQ (GM):
Fiscal Year-End   December
2005 Sales (mil.)   $1.0
1-Year Sales Growth   (37.5%)
2005 Net Income (mil.)   ($59.1)
2005 Employees   32
1-Year Employee Growth   28.0%
Acting Chairman   Jeremy Hayward-Surry
Acting CEO, EVP, and CFO   Peyton J. Marshall
President and COO   Graham P. Allaway
Relevance Score   100 %
Company Name   Panacos Pharmaceuticals, Inc.
Relevance Score   100 %
 Top  
PANACOS PHARMACEUTICALS
Company Name   Alantos Pharmaceuticals  
Address   840 Memorial Dr Cambridge, MA 02139  
Phone   617-577-0011  
Type of Business   Pharmacies  
Relevance Score   82.61%  
Company Name   Paratek Pharmaceuticals, Inc.  
Address   75 Kneeland St Boston, MA 02111  
Phone   617-275-0400  
Type of Business   Laboratories-Medical  
Relevance Score   82.61%  
Company Name   Praecis Pharmaceuticals, Inc.  
Address   830 Winter St Waltham, MA 02451  
Phone   781-795-4100  
Type of Business   Pharmacies  
Relevance Score   82.61%  

Uniform Commercial Code Filings
The search was successfully completed, however no Uniform Commercial Code Filing was found 
 Top  
 Top  
"PANACOS PHARMACEUTICALS"
Serial Number Reg.Number Name Status
76507052   2816809   PANACOS   LIVE  
76507051   2852953   PANACOS PHARMACEUTICALS   LIVE  
75856497     PANACOS PHARMACEUTICALS   DEAD  
75856496     PANACOS   DEAD  
 Top  
The search found the following Canadian Trademarks for this business name. However the search could not assign a high match score. Please verify the results.
PANACOS PHARMACEUTICALS
PANACOS, Registered, 1059969, TMA592371  
PANACOS PHARMACEUTICALS & DESIGN, Registered, 1059968, TMA592384  
 Top  
PANACOS PHARMACEUTICALS
The search found the following Canadian Patents for this business name. However the search could not assign a high match score. Please verify the results.
NumberDescription
2540160   NOVEL TRITERPENE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF  
2514563   INHIBITION OF HIV-1 REPLICATION BY DISRUPTION OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN  
2499038   MONOACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF  
2403718   A METHOD FOR GENERATING IMMUNOGENS THAT ELICIT NEUTRALIZING ANTIBODIES AGAINST FUSION-ACTIVE REGIONS OF HIV ENVELOPE PROTEINS  
2398787   ASSAY FOR DETECTION OF VIRAL FUSION INHIBITORS  
2359892   METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 GP41  
2322868   ACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF  
2223898   BROMINATED HEXAHYDROXYBIPHENYL DERIVATIVES  
2223513   BETULINIC ACID DERIVATIVES AND USES THEREFOR  
2213519   SUKSDORFIN ANALOGS, COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THEREOF  
 Top  
PANACOS PHARMACEUTICALS INC.
Panacos Presents Bevirimat Overview at 10th International Meeting... - 11/20/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Panacos' President and COO,... ... BusinessWire 
Panacos to Present at Bear Stearns SMid-Cap Conference - 11/07/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Bear Stearns SMid-Cap... ... BusinessWire 
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer - 11/01/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Scott McCallister, M.D. has... ... BusinessWire 
Panacos to Present at Cowen Global Health Care Conference - 10/31/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Cowen Global Health Care... ... BusinessWire 
Panacos to Present at Rodman & Renshaw's 8th Annual Healthcare... - 10/30/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Rodman & Renshaw 8th Annual...  ... BusinessWire 
Panacos Announces New Board Member - 10/26/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Laurent Fischer, M.D. has been... ... BusinessWire 
Panacos Reports Third Quarter 2006 Financial Results - 10/26/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its financial results for the third... ... BusinessWire 
Panacos to Report Third Quarter 2006 Results - 10/19/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its... ... BusinessWire 
Panacos to Present at BIO Investor Forum - 10/11/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the BIO Investor Forum to be held... ... BusinessWire 
Panacos to Present Data at 46th Annual ICAAC - 09/20/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced a presentation of the results of a... ... BusinessWire 
Panacos to Present at UBS Global Life Sciences Conference - 09/19/06
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the UBS Global Life Sciences... ... BusinessWire 
"PANACOS PHARMACEUTICALS"
500 Internal Server Error
Internal Server Error. The server encountered an internal error or misconfiguration and was unable to complete your request. ...
http://www.panacos.com/  
Panacos - Careers
Panacos Pharmaceuticals Inc. Human Resources 134 Coolidge Ave. Watertown, MA 02472 Email: hr@panacos.com Fax: 617-923-2529 ...
http://www.panacos.com/careers.htm  
Panacos Pharmaceuticals , Inc.
Panacos Pharmaceuticals , Inc. Panacos.2. Panacos, formerly known as V. I. Technologies, Inc. or VITEX, is developing the next generation of anti-infective ...
http://www.novo.dk/composite-115.htm  
Panacos Pharmaceuticals Inc.
Panacos Pharmaceuticals Inc. is developing the next generation of anti-infective products ... Panacos Pharmaceuticals Inc. News from The BioSpace Beat ...
http://www.biospace.com/company_profile.aspx?CompanyID=246104  
Biospace.com
Panacos Pharmaceuticals Inc. News from The BioSpace Beat ... 19, 2006-- Panacos Pharmaceuticals , Inc. (Nasdaq:PANC), a biotechnology company dedicated to ...
http://www.biospace.com/news_company.aspx?CompanyID=246104  
PANC: Income Statement for PANACOS PHARMA INC - Yahoo! Finance
Sign In to Create/Edit My PortfoliosFree trial of Real-Time Quotes. Panacos Pharmaceuticals Inc. (PANC), On Dec 1: 6.34 Down 0.14 (2.16%). MORE ON PANC ...
http://finance.yahoo.com/q/is?s=panc  
PANC: Profile for PANACOS PHARMA INC - Yahoo! Finance
Panacos Pharmaceuticals , Inc., a development stage biotechnology company, ... Panacos Pharmaceuticals was founded in 1999 and is based in Watertown, ...
http://finance.yahoo.com/q/pr?s=PANC  
=> Nachrichten | Aktien | PANACOS PHARMACEUTICALS | Aktie | News ...
::â–º Nachrichten zur PANACOS PHARMACEUTICALS Aktie. â—„:: Alle News zu Ihren Aktien. Panacos to Present at Cowen Global Health Care Conference :: Panacos COO ...
http://www.finanznachrichten.de/nachrichten-aktien/panacos-pharmaceuticals.asp  
TMF: Panacos Pharmaceuticals (PANC)
Stocks P / Panacos Pharmaceuticals (PANC) Quote, News, Chart · Add This Board To Your Favorites · Post New | Create Poll, No More Skip Back ...
http://boards.fool.com/Messages.asp?bid=117394  
Trials for drug that leaves HIV defenceless - health - 08 June ...
Up to 80 per cent of HIV-positive people on treatment show resistance to one or more of their drugs, according to Graham Allaway of Panacos Pharmaceuticals ...
http://www.newscientist.com/.../mg19025554.400-trials-for-drug...  
Cooley Godward Kronish LLP | News & Publications | Press Releases ...
Cooley Godward LLP represented Panacos Pharmaceuticals in its merger with V.I. Technologies, Inc. The Cooley team, comprised of attorneys from Reston,VA ...
http://www.cooley.com/news/pressreleases.aspx?ID=000038827220  
Company Profile for Panacos Pharmaceuticals Inc Business Wire ...
Company Profile for Panacos Pharmaceuticals Inc from Business Wire in Business & Finance provided free by LookSmart Find Articles.
http://www.findarticles.com/p/articles/mi_m0EIN/is_2006_June_21/ai_n16619017  
Panacos Pharmaceuticals , Inc. (NASDAQ:PANC)
Panacos Pharmaceuticals is developing the next generation of antiviral drugs ... Vitex Closes Merger with Panacos Pharmaceuticals $20 Million Financing Also ...
http://www.mitsuiventures.com/.../  
Panacos Pharmaceuticals Inc - Product Pipeline Report
Panacos Pharmaceuticals Inc - Product Pipeline Report The Panacos Pharmaceuticals Inc Latest Product Pipeline Report contains contact information, ...
http://www.marketresearch.com/product/display.asp?productid=1359971&g=1  
Panacos Pharmaceuticals Inc - Financial Report
Panacos Pharmaceuticals Inc - Financial Report The Panacos Pharmaceuticals Inc Financial Report contains the company’s contact information, details, ...
http://www.marketresearch.com/product/display.asp?productid=1359977&g=1  
digg - HIV Virus Neutralized! New Drug in testing at Panacos ...
Panacos Pharmaceuticals recent experiment with PA-457, an oral drug, has shown promising results in reducing the level of HIV in the blood. ...
http://digg.com/.../HIV_Virus_Neutralized_New_Drug...  
Summary of PANACOS PHARMACEUTICALS , INC. - Yahoo! Finance
Panacos Pharmaceuticals , Inc. seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs ...
http://biz.yahoo.com/e/061109/panc10-q.html  
BioMarket Group AB - Panacos Pharmaceuticals Inc - Product ...
Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, ...
http://www.biomarketgroup.com/.../  
Event Calendar
Panacos Pharmaceuticals , Inc. at BIO Investor Forum 2006, 18-Oct-06 ... Panacos Pharmaceuticals , Inc. at Future Leaders in the Biotech Industry Conferen. ...
http://forbes.ccbn.com/company.asp?ticker=PANC&coid=75423&client=forbes  
Un quart de siècle de sida - Europe - FORUM France 2
... extrait de sous-produits bon marché de l’industrie du papier, le médicament a été conçu et produit par le Panacos Pharmaceuticals , dans le Maryland. ...
http://forums.france2.fr/france2/europe1/Un-quart-siecle-sida-sujet-15855-25.htm